Insider Trading activities of Tocagen Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tocagen Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Tocagen Inc since year 2005. Table 2 shows the detailed insider transactions of Tocagen Inc since 2005. The reporting company's ticker symbol is TOCA. The reporting company's CIK number is 1419041.
The total value of stock buying since 2005 is $1,425,000.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Tocagen Inc (TOCA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-04 142,500 $1,425,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Tocagen Inc insiders (TOCA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-04-19 Das Asha (SVP & Chief Medical Officer) Buy 2,500 10.00 25,000
2017-04-19 Hasnain Faheem (Director) Buy 100,000 10.00 1,000,000
2017-04-19 Schimmel Paul (Director) Buy 10,000 10.00 100,000
2017-04-19 Foletta Mark G (EVP & Chief Financial Officer) Buy 5,000 10.00 50,000
2017-04-19 Gruber Harry E (President, Research & Devel) Buy 25,000 10.00 250,000

Insider trading activities including stock purchases, stock sales, and option exercises of TOCA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Tocagen Inc (symbol TOCA, CIK number 1419041) see the Securities and Exchange Commission (SEC) website.